Saxagliptin

BNF:
6.1.2.3
Status:
Grey
Decision Date:
December 2014
 

Comments

GREY: See type 2 diabetes guidance  

Exceptionality defined as intolerance to the preferred choices (alogliptin/ linagliptin) or restricted by their licensing

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app